Wood C A, Moore A S, Gliatto J M, Ablin L A, Berg R J, Rand W M
Department of Medicine, Tufts University School of Veterinary Medicine, North Grafton, Massachusetts 01536, USA.
J Am Anim Hosp Assoc. 1998 Sep-Oct;34(5):417-21. doi: 10.5326/15473317-34-5-417.
A retrospective analysis was performed on the case records of 32 dogs with Stage I or II splenic hemangiosarcoma that were treated by splenectomy alone and that survived the seven-day postoperative period. Median survival time for these 32 cases was 86 days (mean, 116 days; range, 14 to 470 days), and the one-year survival rate was estimated to be 6.25%. Survival was not influenced by signalment, presenting signs, stage of disease, or clinicopathological findings. The data provides a basis from which to evaluate adjuvant chemotherapy for splenic hemangiosarcoma that is confined to the spleen macroscopically.
对32例I期或II期脾血管肉瘤犬的病例记录进行回顾性分析,这些犬仅接受脾切除术治疗且术后存活超过7天。这32例病例的中位生存时间为86天(平均116天;范围14至470天),估计一年生存率为6.25%。生存情况不受年龄、性别、临床表现、疾病分期或临床病理检查结果的影响。这些数据为评估局限于脾脏的脾血管肉瘤辅助化疗提供了依据。